On December 7, the company "Hemofarm" organized the New Year’s cocktail party for its partners and associates, while the message of the CEO Ronald Seeliger was that the company would remain the reliable partner to the healthcare system in Serbia, state, local community and the overall society.
The cocktail party gathered numerous persons from the public and cultural sphere and it was a good opportunity to sum up the business year of this pharmaceutical giant. This year as well, Hemofarm has kept its leading position in Serbia, BIH and Montenegro, progressing vigorously also in other markets in the region. Apart from the record 5.4 billion of tablets, tens of millions of euros of investments and enormous trust by our consumers in 38 countries on three continents, this year Hemofarm, as a member of STADA Group, has become a part of a big international family - Cinven and Bain Capital.
“Over the course of previous decades, STADA has been one of the leading generic pharmaceutical companies in Europe, and by its good results, Hemofarm also contributed to such a reputation. This year marked the beginning of a new era for us, an era in which this company will be additionally strengthening its position in numerous markets. Product quality and care for consumers are our priority. We do not deny our role of a high-quality partner to the health-care system in Serbia, state and local community, the overall society. Because all of this, I am proud of all the people working for Hemofarm, of all 3000 of them who perform devotedly every day for this orange team “, said the CEO of Hemofarm in his speech.
“Product quality and care for the users are our priority, and we also still play our role of a reliable partner to the healthcare system in Serbia, state, local community and the overall society”, said Seeliger.